Western blot analysis was used to confirm the GILT expression in CWR22Rv1 and PC-3 prostate cancer cell lines versus vector transfected cell lines, which express a puromycin resistance gene but no GILT cDNA. Here, IFI30 is linked to prostate carcinoma.